Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)- Cardiovascular Endpoints

NCT04772248 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04772248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04772248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)- Cardiovascular Endpoints
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
February 22, 2021
Completion date
December 30, 2021
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis